Group One Trading
NGNE icon

Group One Trading’s Neurogene NGNE Stock Holding History

Group One Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-74
Closed -$1.43K – 7670
2023
Q4 		$1.43K Sell
74
-1
-1% -$14 ﹤0.01% 6911
2023
Q3 		$1.18K Hold
75
– – ﹤0.01% 7189
2023
Q2 		$1.25K Hold
75
– – ﹤0.01% 7217
2023
Q1 		$1.05K Sell
75
-25
-25% -$293 ﹤0.01% 6779
2022
Q4 		$1.02K Hold
100
– – ﹤0.01% 6826
2022
Q3 		$1K Hold
100
– – ﹤0.01% 7350
2022
Q2 		$2K Sell
100
-340
-77% -$8.29K ﹤0.01% 7420
2022
Q1 		$17K Buy
440
+405
+1,157% +$23.6K ﹤0.01% 6868
2021
Q4 		$3K Buy
+35
New +$4.26K ﹤0.01% 7796
2021
Q2 		– Sell
-5
Closed -$1.11K – 8424
2021
Q1 		$1K Buy
+5
New +$1.28K ﹤0.01% 7464
2019
Q2 		– Sell
-129
Closed -$6.63K – 5245
2019
Q1 		$7K Sell
129
-1,129
-90% -$57.1K ﹤0.01% 4371
2018
Q4 		$54K Buy
1,258
+961
+324% +$46.8K ﹤0.01% 3523
2018
Q3 		$17K Buy
+297
New +$17.5K ﹤0.01% 4447
2017
Q2 		– Sell
-600
Closed -$172K – 4957
2017
Q1 		$200K Buy
600
+596
+14,900% +$209K ﹤0.01% 2521
2016
Q4 		$1K Hold
4
– – ﹤0.01% 4315
2016
Q3 		$1K Buy
+4
New +$806 ﹤0.01% 4442

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Group One Trading's NGNE Position: Q1 2024 in Review

Group One Trading sold out of Neurogene (NGNE) in Q1 2024, closing a stake of 74 shares — an estimated $1.43K sold.

Group One Trading first reported a position in NGNE in Q3 2016 and held it in 16 quarters. The position peaked at $200K in Q1 2017. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2024.

  • Group One Trading reported no remaining Neurogene position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 74 Neurogene shares in Q1 2024, an estimated $1.43K.
  • Group One Trading first reported a position in Neurogene in Q3 2016 and held it in 16 quarters.
  • Group One Trading's Neurogene position peaked at $200K in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.